Stocktoria
OnKure Therapeutics, Inc. OKUR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-04-09
Chart by TradingView
1/9
Piotroski F — financial health
-2.31
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | $0 | — | — | — |
| Operating income | -$63.0M | -$54.4M | -$36.9M | -$53.8M | -$39.8M |
| Net income | -$59.5M | -$52.7M | -$35.3M | -$52.0M | -$39.8M |
| Operating cash flow | -$51.8M | -$51.1M | -$34.5M | -$47.4M | -$38.0M |
| Free cash flow | -$51.9M | -$51.2M | -$34.8M | -$47.7M | -$38.2M |
| Total assets | $62.1M | $114.9M | $35.7M | $108.2M | $154.0M |
| Total liabilities | $5.9M | $11.1M | $7.8M | $8.2M | $6.8M |
| Shareholders' equity | $56.2M | $103.8M | -$101.8M | -$54.4M | $147.2M |
| Ratios | |||||
| Return on assets | -95.8% | -45.8% | -98.8% | -48.0% | -25.8% |
| Return on equity | -105.9% | -50.7% | 34.7% | 95.5% | -27.0% |
| Current ratio | 10.28 | 10.73 | 4.64 | 14.93 | 24.79 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 377,250 | $1.6M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.31 (distress)
- Working capital / assets 0.884
- Retained earnings / assets -3.449
- EBIT / assets -1.013
- Equity / liabilities 9.47
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001637715 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.